Invention Grant
- Patent Title: Antibodies that bind urokinase plasminogen activator
-
Application No.: US14905409Application Date: 2014-07-15
-
Publication No.: US09908944B2Publication Date: 2018-03-06
- Inventor: Soeren Padkjaer , Jesper Pass , Gustav Roeder , Kasper Almholt , Pernille A. Usher
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Jianjie Hu
- International Application: PCT/EP2014/065136 WO 20140715
- International Announcement: WO2015/007727 WO 20150122
- Main IPC: C07K16/40
- IPC: C07K16/40 ; G01N33/68
Abstract:
The present invention relates to a method of identifying urokinase plasminogen activator (uPA) antibodies. The invention also relates to antibodies that are capable of binding uPA and which are capable of reducing or inhibiting uPA activity. Furthermore, the invention relates to uses for such antibodies, such as therapeutic and pharmaceutical uses.
Public/Granted literature
- US20160159924A1 Anitbodies That Bind Urokinase Plasminogen Activator Public/Granted day:2016-06-09
Information query
